NASDAQ : IMPL

Impel Pharmaceuticals Inc. — Competitors

$0.04 USD

-$0.01 (-27.27%)

Volume
720.03K
Average Volume
1.05M
Market Capitalization
$956K
P/E Ratio
-0.01
Dividend Yield
0.00%
Price Target
Year High
$4.20
Year Low
$0.02
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.60
IMPL vs. The Competition
Properties IMPL ACOR AXDX BLCM
Market Cap $956K $821.03K $859.92K $778.33K
Shares Outstanding $23.9M $1.24M $25.29M $10.41M
P/E Ratio -0.01 -0.0 -0.02 -0.09
EPS -5.52 -203.59 -2.15 -0.81
Day Low 0.0212 0.6116 0.034 0.0717
Day High 0.05 0.85 0.08 0.09
Year Low 0.0212 0.6116 0.01 0.06
Year High 4.2 24.2 2.09 1.31
Average Price 50 0.339731 12.103 0.60269 0.1057822
Average Price 200 0.96935177 13.16565 1.27845 0.26351684
Volume 720.03K 321.67K 13.82M 6059
Average Volume - - - -
IMPL Top Competitors
Symbol Name Last Change %Chg Volume
ACOR Acorda Therapeutics, Inc. $0.661 -0.209 -24.02% 321.67K
AXDX Accelerate Diagnostics, Inc. $0.034 0 0.00% 13.82M
BLCM Bellicum Pharmaceuticals, Inc. $0.07475 -0.0053 -6.68% 6059